Fundraising FoxNephron Pharmaceuticals
Orlando, US · 3 known investors
Find your way into Nephron Pharmaceuticals
Founders & leadership
LW
Lou Wood KennedyFor Issuer and Additional Issuer
WP
William P. KennedyFor Issuer and Additional Issuer
Investors · 3
BlackRockreportedMexico City
How we know: funding news · gaebler.com · Not right? Tell us
Also in the syndicate · 2
National Association of College StoresPNC Bank
Funding
SEC filings, press & company announcements$425M disclosed across 2 rounds · 2014–2023
- $350MraisedSep 2023 · 2 sources
Blackrock Capital Investment Corporation, National Association of College Stores, PNC Bank
Source ↗
▶$75MraisedAug 2014 · 8 investors · Business ServicesRule 506(b)
▶$75MraisedAug 2014 · 8 investors · Business Services
Rule 506(b)Officers, directors & promoters on the filing
- Lou Wood KennedyExecutive Officer, Director
- William P. KennedyDirector
- Offering amount
- $75M
- Amount sold
- $75M
- Minimum investment
- $475K
- Sales commissions
- $500K
- Placement agents
- Huron Transaction Advisory LLC
- First sale
- Aug 2014
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nephron Pharmaceuticals's investors?
- Nephron Pharmaceuticals's investors include BlackRock.
- How much funding has Nephron Pharmaceuticals raised?
- Nephron Pharmaceuticals has disclosed $425M raised across 2 rounds.
- Where is Nephron Pharmaceuticals headquartered?
- Nephron Pharmaceuticals is headquartered in Orlando, US.